• Information for health professionals conferences

Access to skin prick testing reagents

Skin prick testing is the primary mode of testing for immediate IgE-mediated allergy. This testing is widely practised, carries very low risk of side effects to patients and provides high quality information when performed optimally and interpreted correctly. 

This webpage contains information about:

Suppliers | Availability | TGA applications | Further information

Suppliers 
Stallergenes Greer
Suppliers of Stallergenes Greer, Hollister Stier, Albey and Hymenoptera products
PO Box 281, Mona Vale NSW 1660 Australia
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 
Phone: 1800 824 166 (AU)
 
AMSL Allergy
 
Suppliers of Inmunotek and ALK products
2 McCabe Place, Chatswood NSW 2067 Australia
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: 02 9882 3666 (AU)
 
Gamma Allergy 
 
Suppliers of Gamma Allergy products
Gold Coast, QLD, Australia
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 
Phone: 1300 881 405 (AU)

 
Ferrer Pharma Pty Ltd
 
Suppliers of Lofarma, Diater (including antibiotic and venom allergens) and Chemotechnique patch test products
4 Pinehurst Ave, Rouse Hill, NSW 2155
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: 1300 022 789
Availability

Since mid-February 2016, a range of Greer Skin Prick Test reagents is available, that are authorised for distribution in Australia under section 19A of the Therapeutic Goods Act 1989, which means that no Authorised Prescriber status is required to order them. They are supplied as 5 mL vials by Stallergenes Greer in the USA and are exclusively distributed in Australia by the EBOS Group Pty Ltd for Stallergenes Australia Pty Ltd trading as Stallergenes Greer.

Since 2008 some Hollister Stier allergen extracts for skin prick testing that were registered with the Therapeutic Goods Administration (TGA) for use in Australia have been discontinued and are therefore no longer available. Other Hollister Stier allergen extracts for skin prick testing that are still available and are registered with the Therapeutic Goods Administration (TGA) can be ordered by medical practitioners without having to gain endorsement as an authorised prescriber.

Since 2008 it has been necessary for medical practitioners to use skin testing products that are not TGA registered.  This requires endorsement as an authorised prescriber (please refer to information below) or a Specal Access Scheme (SAS) C application.  Patient consent needs to be obtained before use of these products and a template may be adapted for this purpose.docxSPT_Consent_form_template16.02 KB

TGA Authorised Prescriber and SAS C applications

Medical practitioners can access unregistered products using the following options:

(1) Section 19(5): Obtain "Authorised Prescriber status" by endorsement from a medical college e.g. Royal College of Pathogists of Australasia (RCPA), Royal Australasia College of Physicians (RACP).  ASCIA has obtained this on behalf of its Full (ordinary) members who are fellows of the RCPA and/or RACP for some unregistered skin testing products.  For details go to www.tga.gov.au/form/authorised-prescribers

(2) Section 19(5): Obtain "Authorised Prescriber status" by endorsement by an ethics committee: This can be used to access unregistered skin testing products for some ASCIA members who work in hospitals and/or universities with ethic committees.  For details go to www.tga.gov.au/form/authorised-prescribers

(3) Special Access Scheme (SAS) Category C: This is a notification pathway which allows health practitioners to supply goods that are deemed to have an established history of use without first seeking prior approval. The goods deemed to have an established history of use are specified in a list along with their indications and the type of health practitioner authorised to supply these products for the respective indications. For details go to www.tga.gov.au/form/special-access-scheme

Further information
 

 

Content updated April 2018

Disclaimer and Privacy

The ASCIA website is intended for use by ASCIA members, other health professionals, the general public and media. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors and Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the
HONcode standard for
trustworthy health
 information.

Verify here.